By Professor Ric Day

Journal articles

Day RO; Williams KM; Graham GG; Lee EJ; Knihinicki RD; Champion GD, 1988, 'Stereoselective disposition of ibuprofen enantiomers in synovial fluid', Clinical Pharmacology and Therapeutics, 43, pp. 480 - 487, http://dx.doi.org/10.1038/clpt.1988.62

Williams KM; Day RO, 1988, 'The contribution of enantiomers to variability in response to anti-inflammatory drugs.', Agents and actions. Supplements, 24, pp. 76 - 84, http://dx.doi.org/10.1007/978-3-0348-9160-8_7

Day R; Paull P; Lam S; Swanson B; Williams K; Wade D, 1988, 'The effect of concurrent aspirin upon plasma concentrations of tenoxicam.', British Journal of Clinical Pharmacology, 26, pp. 455 - 462, http://dx.doi.org/10.1111/j.1365-2125.1988.tb03405.x

Keogh A; Day R; Critchley L; Duggin G; Baron D, 1988, 'The effect of food and cholestyramine on the absorption of cyclosporine in cardiac transplant recipients', Transplantation Proceedings, 20, pp. 27 - 30

Day RO; Graham GG; Willia KM; Brooks PM, 1988, 'Variability in Response to NSAIDs: Fact or Fiction?', Drugs, 36, pp. 643 - 651, http://dx.doi.org/10.2165/00003495-198836060-00001

Reilly DK; Ray JE; Day RO; Wodak A; O'Connor D; Thompson J, 1987, 'Classification of overdose/self-poisoning presentations to an accident and emergency department', International Journal of the Addictions, 22, pp. 941 - 955

WING LMH; MOULDS RFW; SHENFIELD GM; DAY RO, 1987, 'DRUG ADVERTISING - REPLY', MEDICAL JOURNAL OF AUSTRALIA, 147, pp. 361 - 361, http://dx.doi.org/10.5694/j.1326-5377.1987.tb133532.x

MOULDS RFW; DAY RO, 1987, 'DRUG ADVERTISING', MEDICAL JOURNAL OF AUSTRALIA, 147, pp. 52 - 52, http://dx.doi.org/10.5694/j.1326-5377.1987.tb133252.x

PATAPANIAN H; SAMBROOK PN; BROWNE CD; CHAMPION GD; DAY RO; COHEN ML, 1987, 'ONCHOGENICITY OF CHLORAMBUCIL IN RHEUMATOID-ARTHRITIS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 17, pp. 124 - 124, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1987G353300058&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mant A; Wodak A; Day R, 1987, 'Benzodiazepine dependence. Strategies for prevention and withdrawal', Current Therapeutics, 28, pp. 59 - 79

Reilly DK; Ray JE; Day RO; Wodak A; Bsocstud DOC; Thompson J, 1987, 'Classification of overdose/self-poisoning presentations to an accident and emergency department', Substance Use and Misuse, 22, pp. 941 - 955, http://dx.doi.org/10.3109/10826088709109691

Day RO; Graham GG; Williams KM; David Champion G; de Jager J, 1987, 'Clinical pharmacology of non-steroidal anti-inflammatory drugs', Pharmacology and Therapeutics, 33, pp. 383 - 433, http://dx.doi.org/10.1016/0163-7258(87)90072-6

Day R; Lam S; Paull P; Wade D, 1987, 'Effect of food and various antacids on the absorption of tenoxicam.', British Journal of Clinical Pharmacology, 24, pp. 323 - 328, http://dx.doi.org/10.1111/j.1365-2125.1987.tb03176.x

Day R; Brooks P, 1987, 'Variations in response to non‐steroidal anti‐inflammatory drugs.', British Journal of Clinical Pharmacology, 23, pp. 655 - 658, http://dx.doi.org/10.1111/j.1365-2125.1987.tb03098.x

Sambrook PN; Champion GD; Browne CD; Cohen ML; Compton P; Day RO; Jager JD, 1986, 'Comparison of methotrexate with azathioprine or 6-mercaptopurine in refractory rheumatoid arthritis: A life-table analysis', Rheumatology, 25, pp. 372 - 375, http://dx.doi.org/10.1093/rheumatology/25.4.372

Goadsby PJ; Day RO; Kwan YL; Miners J; Birkett DJ, 1986, '6-MERCAPTOPURINE-RELATED LEUCOPENIA AND IN VIVO XANTHINE OXIDASE ACTIVITY', The Lancet, 328, pp. 869 - 870, http://dx.doi.org/10.1016/S0140-6736(86)92911-9

Williams K; Day R; Knihinicki R; Duffield A, 1986, 'The stereoselective uptake of ibuprofen enantiomers into adipose tissue', Biochemical Pharmacology, 35, pp. 3403 - 3405, http://dx.doi.org/10.1016/0006-2952(86)90443-0

SAMBROOK PN; CHAMPION GD; COMPTON PJ; BROWNE CD; COHEN M; DAY RO; DEJAGER JP, 1986, 'THERAPEUTIC OUTCOME WITH METHOTREXATE AND AZATHIOPRINE IN RHEUMATOID-ARTHRITIS - A LIFE TABLE ANALYSIS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 16, pp. 144 - 144, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1986A500500119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ray JE; Reilly DK; Day RO, 1986, 'Drugs involved in self-poisoning: Verification by toxicological analysis', Medical Journal of Australia, 144, pp. 455 - 457, http://dx.doi.org/10.5694/j.1326-5377.1986.tb101047.x

Davis A; Day RO; Begg EJ, 1986, 'INTERACTIONS BETWEEN NON‐STEROIDAL ANTI‐INFLAMMATORY DRUGS AND ANTIHYPERTENSIVES AND DIURETICS', Australian and New Zealand Journal of Medicine, 16, pp. 537 - 546, http://dx.doi.org/10.1111/j.1445-5994.1986.tb02031.x

WILLIAMS KM; DAY RO; KNIHINICKI RD; DUFFIELD AM, 1986, 'STEREOSELECTIVE INCORPORATION OF IBUPROFEN ENANTIOMERS INTO ADIPOSE-TISSUE IN RATS AND MAN', ACTA PHARMACOLOGICA ET TOXICOLOGICA, 59, pp. 192 - 192, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1986D896000552&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

DAY RO; WILLIAMS KM; LEE EJ; KNIHINICKI R, 1985, 'DISPOSITION OF ENANTIOMERS OF IBUPROFEN IN PLASMA AND SYNOVIAL-FLUID IN ARTHRITIC DISEASE', CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 8, pp. A58 - A58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1985AQS8500134&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lee E; Williams K; Day R; Graham G; Champion D, 1985, 'Stereoselective disposition of ibuprofen enantiomers in man.', British Journal of Clinical Pharmacology, 19, pp. 669 - 674, http://dx.doi.org/10.1111/j.1365-2125.1985.tb02694.x

Williams KM; Day RO, 1985, 'Stereoselective disposition--basis for variability in response to NSAID's.', Agents and actions. Supplements, 17, pp. 119 - 126, http://dx.doi.org/10.1007/978-3-0348-7720-6_14

Day RO, 1985, 'Variability in response to NSAID.', Agents and actions. Supplements, 17, pp. 15 - 19, http://dx.doi.org/10.1007/978-3-0348-7720-6_1

Ray JD; Day RO, 1984, 'High-performance liquid chromatographic determination of a new anti-inflammatory agent, nabumetone, and its major metabolite in plasma using fluorimetric detection', Journal of Chromatography B: Biomedical Sciences and Applications, 336, pp. 234 - 239, http://dx.doi.org/10.1016/S0378-4347(00)85146-4

Graham GG; Day RO; Champion GD; Lee E; Newton K, 1984, 'Aspects of the clinical pharmacology of non-steroidal anti- inflammatory drugs', Clinics in Rheumatic Diseases, 10, pp. 229 - 249

Day RO; Graham GG; Champion GD; Lee E, 1984, 'Anti-rheumatic drug interactions', Clinics in Rheumatic Diseases, 10, pp. 251 - 275

McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN, 1984, 'Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate', Medical Journal of Australia, 141, pp. 349 - 351, http://dx.doi.org/10.5694/j.1326-5377.1984.tb132803.x

Lee EJD; Williams KM; Graham GG; Day RO; Champion GD, 1984, 'Liquid chromatographic determination and plasma concentration profile of optical isomers of ibuprofen in humans', Journal of Pharmaceutical Sciences, 73, pp. 1542 - 1544, http://dx.doi.org/10.1002/jps.2600731112

DAY RO; HARRIS G; BROWN M; GRAHAM G, 1983, 'ASPIRIN GLUCOCORTICOSTEROID INTERACTION IN MAN', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 10, pp. 717 - 717, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RW31100128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ray JE; Day RO, 1983, 'High‐performance liquid chromatographic analysis of diflunisal in plasma and urine: Application to pharmacokinetic studies in two normal volunteers', Journal of Pharmaceutical Sciences, 72, pp. 1403 - 1405, http://dx.doi.org/10.1002/jps.2600721209

Day RO; Shen DD; Azarnoff DL, 1983, 'Induction of Salicyluric Acid Formation in Rheumatoid Arthritis Patients Treated with Salicylates', Clinical Pharmacokinetics, 8, pp. 263 - 271, http://dx.doi.org/10.2165/00003088-198308030-00005

BEGG EJ; CHINWAH PM; WEBB C; DAY RO; WADE DN, 1983, 'INTERACTION OF MEXILETINE WITH PHENYTOIN', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 10, pp. 191 - 192, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983QN17900029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

RAY JE; REILLY DK; HAAVISTO T; PAULL PD; DAY RO, 1983, 'SURVEY OF DRUG-ABUSE PATTERNS IN A CASUALTY DEPARTMENT POPULATION', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 10, pp. 715 - 716, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RW31100125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sambrook PN; Browne CD; Champion GD; Day RO; Vallance JB; Warwick N, 1982, 'Terminations of treatment with gold sodium thiomalate in rheumatoid arthritis', Journal of Rheumatology, 9, pp. 932 - 934

Day RO; Sambrook P; Champion GD; Graham GG, 1982, 'Antimalarials in rheumatic diseases', Australian and New Zealand Journal of Medicine, 12, pp. 645 - 649, http://dx.doi.org/10.1111/j.1445-5994.1982.tb02658.x

Champion GD; Bieri D; Browne CD, 1982, 'Auranofin in rheumatoid arthritis', Journal of Rheumatology, 9, pp. 137 - 145

DAY RO; FURST DE; DROMGOOLE SH; PAULUS HE, 1982, 'DECLINE OF STEADY-STATE SERUM SALICYLIC-ACID CONCENTRATIONS WITH TIME IN NORMAL VOLUNTEERS GIVEN HIGH-DOSE ASPIRIN', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 12, pp. 557 - 558, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN87700049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

RAY JE; DAY RO, 1982, 'DIFLUNISAL, A SPECIFIC ANALYTICAL PROCEDURE AND PRELIMINARY PHARMACOKINETICS IN MAN', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 12, pp. 572 - 572, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN87700093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ray JE; Day RO, 1982, 'Diflunisal, a specific analytical procedure and preliminary pharmacokinetics in man', Clinical and Experimental Pharmacology and Physiology, 9, pp. 453

Begg E; Chinwah P; Webb C; Day R; Wade D, 1982, 'Enhanced metabolism of mexiletine after phenytoin administration.', British Journal of Clinical Pharmacology, 14, pp. 219 - 223, http://dx.doi.org/10.1111/j.1365-2125.1982.tb01965.x

Day RO; Furst DE; Dromgoole SH; Kamm B; Roe R; Paulus HE, 1982, 'Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis', Clinical Pharmacology and Therapeutics, 31, pp. 733 - 740, http://dx.doi.org/10.1038/clpt.1982.103

HARRIS G; CAIRNS D; BIERI D; CHAMPION D; DAY R; GRAHAM G, 1982, 'RESPONSE OF RHEUMATOID-ARTHRITIS TO SLOWLY ACTING ANTI-RHEUMATIC DRUGS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 12, pp. 561 - 561, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN87700060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Day RO; Pearson CM, 1981, 'Primary inflammatory muscle diseases', Comprehensive Therapy, 7, pp. 22 - 30

Day RO; Furst DE; Dromgoole SH, 1981, 'Decline in steady-state serum levels of salicylate in normal subjects: Preliminary results', Clinical and Experimental Pharmacology and Physiology, 8

Day RO, 1981, 'Effects of exercise performance on drugs used musculoskeletal disorders', Medicine and Science in Sports and Exercise, 13, pp. 272 - 275, http://dx.doi.org/10.1249/00005768-198104000-00013

Day RO; Dromgoole SH; Furst DE; Hignite C; Paulus HE, 1981, 'Formation of methyl ester of salicyluric acid during quantitation of salicyluric acid in urine by high‐pressure liquid chromatography', Journal of Pharmaceutical Sciences, 70, pp. 1090 - 1092, http://dx.doi.org/10.1002/jps.2600700934

Day RO; Furst DE; Dromgoole SH, 1981, 'Naproxen serum level response relationship in rheumatoid arthritis', Australian and New Zealand Journal of Medicine, 11, pp. 720

Furst DE; Day RO; Dromgoole SH, 1981, 'Steady-state serum level vs response relationship for naproxen in rheumatoid arthritis', Clinical Pharmacology and Therapeutics, 29, pp. 247

Back to profile page